• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼内血管内皮生长因子拮抗剂治疗后眼内炎:大学转诊中心六年经验。 (请注意,原文中“vascular [corrected] endothelial growth factor antagonists”中的“vascular”应改为“vascular endothelial”。)

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.

机构信息

Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida 33418, USA.

出版信息

Retina. 2011 Apr;31(4):662-8. doi: 10.1097/IAE.0b013e31821067c4.

DOI:10.1097/IAE.0b013e31821067c4
PMID:21836400
Abstract

PURPOSE

To assess the rate of infectious endophthalmitis and to describe the clinical and microbiological features of eyes that develop clinically suspected endophthalmitis after an intravitreal injection of vascular endothelial growth factor antagonists.

METHODS

The medical records of patients undergoing intravitreal injections of anti-vascular endothelial growth factor agents from January 1, 2005, through December 31, 2010, at a single university referral center and associated satellite clinics were retrospectively analyzed to determine the rate of infectious endophthalmitis after intravitreal anti-vascular endothelial growth factor injections.

RESULTS

Twelve cases (11 patients) of clinically suspected endophthalmitis were identified after a total of 60,322 injections (0.02%; 95% confidence interval, 0.0114%-0.0348%). Of the 12 cases, 11 presented within 3 days of the injection. Of the 7 culture-positive cases, 5 were because of Streptococcus species. In 4 of the 5 Streptococcus cases, final visual acuity was hand motions or worse. The rate of clinically suspected endophthalmitis was 0.018% after bevacizumab and 0.027% after ranibizumab injections.

CONCLUSION

A very low rate of endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor agents was observed. Patients typically presented within 3 days of injection. Streptococcus species was the most common bacteria isolated, and it was generally associated with poor visual outcomes.

摘要

目的

评估感染性眼内炎的发生率,并描述接受血管内皮生长因子拮抗剂玻璃体内注射后发生临床疑似眼内炎的眼部的临床和微生物学特征。

方法

回顾性分析 2005 年 1 月 1 日至 2010 年 12 月 31 日期间在一家大学转诊中心和相关卫星诊所接受血管内皮生长因子拮抗剂玻璃体内注射的患者的病历,以确定血管内皮生长因子拮抗剂玻璃体内注射后感染性眼内炎的发生率。

结果

在总共 60322 次注射(0.02%;95%置信区间,0.0114%-0.0348%)后,发现 12 例(11 例患者)发生临床疑似眼内炎。12 例中,11 例在注射后 3 天内出现。在 7 例培养阳性的病例中,有 5 例是链球菌属。在 5 例链球菌病例中,最终视力为手动或更差。贝伐单抗和雷珠单抗注射后临床疑似眼内炎的发生率分别为 0.018%和 0.027%。

结论

观察到血管内皮生长因子拮抗剂玻璃体内注射后眼内炎的发生率非常低。患者通常在注射后 3 天内出现。链球菌属是最常见的分离菌,通常与视力不良结局相关。

相似文献

1
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.眼内血管内皮生长因子拮抗剂治疗后眼内炎:大学转诊中心六年经验。 (请注意,原文中“vascular [corrected] endothelial growth factor antagonists”中的“vascular”应改为“vascular endothelial”。)
Retina. 2011 Apr;31(4):662-8. doi: 10.1097/IAE.0b013e31821067c4.
2
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.抗血管内皮生长因子药物玻璃体内注射后眼内炎的结局和相关危险因素。
Ophthalmology. 2011 Oct;118(10):2028-34. doi: 10.1016/j.ophtha.2011.02.034. Epub 2011 Jun 25.
3
Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.抗血管内皮生长因子眼内注射后眼内炎发生率的评估。
Ophthalmologica. 2011;226(3):145-50. doi: 10.1159/000329863. Epub 2011 Jul 29.
4
Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.玻璃体培养指导下内眼注药后眼内炎治疗策略的改变
Am J Ophthalmol. 2019 Nov;207:224-231. doi: 10.1016/j.ajo.2019.06.008. Epub 2019 Jun 13.
5
Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.玻璃体内注射贝伐单抗、雷珠单抗和阿柏西普后的注射后眼内炎发生率及特征
Am J Ophthalmol. 2016 May;165:88-93. doi: 10.1016/j.ajo.2016.02.028. Epub 2016 Mar 2.
6
Endophthalmitis after intravitreal injection: the importance of viridans streptococci.眼内注射后眼内炎:草绿色链球菌的重要性。
Retina. 2011 Sep;31(8):1525-33. doi: 10.1097/IAE.0b013e318221594a.
7
Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.局部使用利多卡因凝胶麻醉行玻璃体腔抗血管内皮生长因子药物注射后眼内炎的发生率。
Retina. 2011 Apr;31(4):669-72. doi: 10.1097/IAE.0b013e3181ef463d.
8
Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.抗血管内皮生长因子药物玻璃体内注射后眼内炎的荟萃分析:致病病原体和可能的预防策略。
Retina. 2011 Apr;31(4):654-61. doi: 10.1097/IAE.0b013e31820a67e4.
9
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.门诊环境中玻璃体内注射抗血管内皮生长因子治疗相关的眼内炎
Am J Ophthalmol. 2008 May;145(5):879-82. doi: 10.1016/j.ajo.2007.12.036. Epub 2008 Mar 10.
10
Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.马萨诸塞眼耳医院的玻璃体腔内注射:治疗适应证分析和注射后眼内炎发生率。
Br J Ophthalmol. 2013 Apr;97(4):460-5. doi: 10.1136/bjophthalmol-2012-302435. Epub 2013 Feb 6.

引用本文的文献

1
Cytometric Evaluation of Cytokine Factors in Serum and Vitreous from Endophthalmitis Patients: Correlated Elevation in Neutrophil Markers.眼内炎患者血清和玻璃体中细胞因子的流式细胞术评估:中性粒细胞标志物的相关升高
Biomedicines. 2025 May 22;13(6):1269. doi: 10.3390/biomedicines13061269.
2
Metabolomic Profiling of Ocular Fluid Identifies Host Response Factors for Risk Stratification in Bacterial Endophthalmitis.眼内液的代谢组学分析确定了细菌性眼内炎风险分层的宿主反应因素。
Invest Ophthalmol Vis Sci. 2025 May 1;66(5):27. doi: 10.1167/iovs.66.5.27.
3
Diagnostic and Therapeutic Utility of Extracellular Vesicles in Ocular Disease.
细胞外囊泡在眼部疾病中的诊断和治疗效用
Int J Mol Sci. 2025 Jan 20;26(2):836. doi: 10.3390/ijms26020836.
4
Endophthalmitis: a bibliometric study and visualization analysis from 1993 to 2023.眼内炎:1993 年至 2023 年的文献计量研究与可视化分析。
Front Cell Infect Microbiol. 2024 Jul 16;14:1355397. doi: 10.3389/fcimb.2024.1355397. eCollection 2024.
5
Use of corticosteroids in non-infectious uveitis - expert consensus in Taiwan.台湾非感染性葡萄膜炎皮质类固醇使用的专家共识。
Ann Med. 2024 Dec;56(1):2352019. doi: 10.1080/07853890.2024.2352019. Epub 2024 May 15.
6
Fungal Diseases Caused by Serious Contamination of Pharmaceuticals and Medical Devices, and Rapid Fungal Detection Using Nano-Diagnostic Tools: A Critical Review.严重污染的药品和医疗器械引起的真菌病,以及使用纳米诊断工具的快速真菌检测:批判性评价。
Curr Microbiol. 2023 Nov 17;81(1):10. doi: 10.1007/s00284-023-03506-7.
7
Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome.玻璃体内注射后眼内炎:发病率、特征、管理及结果
J Ophthalmol. 2023 Nov 6;2023:9212524. doi: 10.1155/2023/9212524. eCollection 2023.
8
Survey of Intravitreal Injection Practice Patterns Among Retina Specialists.视网膜专科医生玻璃体内注射实践模式调查
J Vitreoretin Dis. 2020 Jan 23;4(4):306-311. doi: 10.1177/2474126419899514. eCollection 2020 Jul-Aug.
9
Management Patterns and Outcomes for Intravitreal Injection-Related Endophthalmitis.玻璃体内注射相关性眼内炎的管理模式与结局
J Vitreoretin Dis. 2021 Jul 28;6(3):188-193. doi: 10.1177/24741264211028435. eCollection 2022 May-Jun.
10
Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review.阈下微脉冲激光治疗糖尿病性黄斑水肿:综述
J Clin Med. 2022 Dec 29;12(1):274. doi: 10.3390/jcm12010274.